Literature DB >> 17673498

Characteristics of orthostatic hypotension in Parkinson's disease.

Hisayoshi Oka1, Masayuki Yoshioka, Kenji Onouchi, Masayo Morita, Soichiro Mochio, Masahiko Suzuki, Toshiaki Hirai, Yasuhiko Ito, Kiyoharu Inoue.   

Abstract

Clinical symptoms of Parkinson's disease (PD) include not only motor distress but also autonomic dysfunction. Orthostatic hypotension (OH) occurs in one-fifth to one-half of all patients with PD. We examined the relation of this type of hypotension to clinical features and cardiovascular parameters such as cardiac 123I-meta-iodobenzylguanidine (MIBG) uptake, changes on the Valsalva maneuver, and plasma norepinephrine concentrations on head-up tilt-table testing (HUT). We performed HUT in 55 patients with PD and divided them into two groups according to the presence or absence of OH, defined as a drop in systolic blood pressure (SBP mmHg) by 20 mmHg or more on standing. We evaluated cardiac sympathetic function by 123I-MIBG scintigraphy and assessed cardiovascular autonomic function by using the Valsalva maneuver in all subjects. We also performed HUT, 123I-MIBG scintigraphy and assessed cardiovascular autonomic function by using the Valsalva maneuver in 20 controls. The results of HUT showed that 20 patients had OH and 35 did not. The hypotension was associated with gender, older age, longer disease duration, posture and gait instability phenotype, low mini-mental state examination scores and visual hallucinations. Cardiac 123I-MIBG uptakes were lower in patients with OH. SBP fell further during early second phase in patients with OH than in patients without the condition and their increase in SBP during the late second phase and the overshoot of SBP during the fourth phase were lower. The blood pressure recovery time during the fourth phase on the Valsalva maneuver was longer in patients with OH than in those without OH. There was, however, no association between the fall in SBP on HUT and baroreflex sensitivity or the plasma norepinephrine concentrations, adjusted by age, disease duration, disease severity and dopaminergic medication using multiple regression analyses. Patients without OH already had impaired cardiac sympathetic and baroreceptor reflex functions as early abnormalities of cardiovascular autonomic control. Our results suggest that pronounced vasomotor and cardiac sympathetic dysfunction is the primary cause of OH in PD, although baroreceptor reflex failure may also make a minor contribution. It was unclear whether vasomotor and cardiac sympathetic dysfunction in patients with PD was caused primarily by the impairment of preganglionic or postganglionic lesions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17673498     DOI: 10.1093/brain/awm174

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  11 in total

Review 1.  [Nonmotor symptoms in Parkinson's disease].

Authors:  W H Jost
Journal:  Nervenarzt       Date:  2017-08       Impact factor: 1.214

Review 2.  Recent developments in innervation imaging using iodine-123-metaiodobenzylguanidine scintigraphy in Lewy body diseases.

Authors:  Giorgio Treglia; Ernesto Cason; Anna Gabellini; Alessandro Giordano; Giorgio Fagioli
Journal:  Neurol Sci       Date:  2010-03-10       Impact factor: 3.307

Review 3.  Animal models of the non-motor features of Parkinson's disease.

Authors:  Kimberly McDowell; Marie-Françoise Chesselet
Journal:  Neurobiol Dis       Date:  2012-01-03       Impact factor: 5.996

4.  Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats.

Authors:  Christopher J Barnum; Nirmal Bhide; David Lindenbach; Margaret A Surrena; Adam A Goldenberg; Stefanie Tignor; Anna Klioueva; Hannah Walters; Christopher Bishop
Journal:  Pharmacol Biochem Behav       Date:  2011-09-25       Impact factor: 3.533

5.  Effects of levodopa therapy on global left ventricular systolic function in patients with Parkinson disease.

Authors:  Zeki Yüksel Günaydın; Osman Bektaş; Ahmet Karagöz; Fahriye Feriha Özer
Journal:  Wien Klin Wochenschr       Date:  2016-06-24       Impact factor: 1.704

6.  Systemic postganglionic adrenergic studies do not distinguish Parkinson's disease from multiple system atrophy.

Authors:  Axel Lipp; Paola Sandroni; Phillip A Low
Journal:  J Neurol Sci       Date:  2009-04-05       Impact factor: 3.181

7.  Carotid artery thickening and neurocirculatory abnormalities in de novo Parkinson disease.

Authors:  Joong-Seok Kim; Yoon-Sang Oh; Kwang-Soo Lee; In-Uk Song; In-Seok Park; Dong-Won Yang; Ja-Seong Koo; David S Goldstein
Journal:  J Neural Transm (Vienna)       Date:  2014-04-02       Impact factor: 3.575

Review 8.  Orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism.

Authors:  Seyed-Mohammad Fereshtehnejad; Johan Lökk
Journal:  Parkinsons Dis       Date:  2014-02-02

Review 9.  Clozapine in Parkinsonian Rest Tremor: A Review of Outcomes, Adverse Reactions, and Possible Mechanisms of Action.

Authors:  Tay Kay Yaw; Susan H Fox; Anthony E Lang
Journal:  Mov Disord Clin Pract       Date:  2015-12-30

10.  The diagnostic discrimination of cutaneous α-synuclein deposition in Parkinson disease.

Authors:  Christopher H Gibbons; Jennifer Garcia; Ningshan Wang; Ludy C Shih; Roy Freeman
Journal:  Neurology       Date:  2016-07-06       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.